◆英語タイトル:Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8012452
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月5日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Intellipharmaceutics International Inc (IPCI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Intellipharmaceutics International Inc (Intellipharmaceutics) is a research based pharmaceutical company that develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company’s portfolio encompasses controlled-release candidates for management of neuropathic pain, attention deficit hyperactivity disorder (ADHD), schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder and panic disorder; type 2 diabetes; and stomach ulcers. It offers a comprehensive range of pre-formulation studies, design, and development through to regulatory approval. The company’s drug delivery systems and pipeline candidates are based on its Hypermatrix, a proprietary multidimensional controlled-release drug delivery technology. Intellipharmaceutics’ is headquartered in Toronto, Ontario, Canada.
Intellipharmaceutics International Inc Key Recent Developments
Oct 10,2017: Intellipharmaceutics Announces Third Quarter 2017 Results
Sep 01,2017: Intellipharmaceutics appoints new Chief Financial Officer
Sep 01,2017: Intellipharmaceutics Appoints New Chief Financial Officer
Aug 08,2017: Intellipharmaceutics Announces Resignation of CFO
Jul 11,2017: Intellipharmaceutics Announces Second Quarter 2017 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Intellipharmaceutics International Inc – Key Facts 5
Intellipharmaceutics International Inc – Key Employees 6
Intellipharmaceutics International Inc – Key Employee Biographies 7
Intellipharmaceutics International Inc – Major Products and Services 8
Intellipharmaceutics International Inc – History 9
Intellipharmaceutics International Inc – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Intellipharmaceutics International Inc – Business Description 11
R&D Overview 11
Intellipharmaceutics International Inc – SWOT Analysis 12
SWOT Analysis – Overview 12
Intellipharmaceutics International Inc – Strengths 12
Intellipharmaceutics International Inc – Weaknesses 13
Intellipharmaceutics International Inc – Opportunities 14
Intellipharmaceutics International Inc – Threats 15
Intellipharmaceutics International Inc – Key Competitors 16
Section 3 – Company Financial Ratios 17
Financial Ratios – Capital Market Ratios 17
Financial Ratios – Annual Ratios 18
Performance Chart 20
Financial Performance 20
Financial Ratios – Interim Ratios 21
Financial Ratios – Ratio Charts 22
Section 4 – Company’s Lifesciences Financial Deals and Alliances 23
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 23
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 24
Intellipharmaceutics International Inc, Recent Deals Summary 25
Section 5 – Company’s Recent Developments 26
Oct 10, 2017: Intellipharmaceutics Announces Third Quarter 2017 Results 26
Sep 01, 2017: Intellipharmaceutics Appoints New Chief Financial Officer 28
Aug 08, 2017: Intellipharmaceutics Announces Resignation of CFO 29
Jul 11, 2017: Intellipharmaceutics Announces Second Quarter 2017 Results 30
May 26, 2017: Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement to Replace Expiring Shelf Registration Statement 32
Apr 11, 2017: Intellipharmaceutics Announces First Quarter 2017 Results 33
Mar 16, 2017: Intellipharmaceutics Announces TSX Trading Symbol Change to “IPCI” 36
Feb 10, 2017: Intellipharmaceutics Announces 2016 Year End Results 37
Oct 13, 2016: Intellipharmaceutics Announces Third Quarter 2016 Results 40
Jul 13, 2016: Intellipharmaceutics Announces Second Quarter 2016 Results 42
Section 6 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Tables
Intellipharmaceutics International Inc, Key Facts 5
Intellipharmaceutics International Inc, Key Employees 6
Intellipharmaceutics International Inc, Key Employee Biographies 7
Intellipharmaceutics International Inc, Major Products and Services 8
Intellipharmaceutics International Inc, History 9
Intellipharmaceutics International Inc, Subsidiaries 10
Intellipharmaceutics International Inc, Key Competitors 16
Intellipharmaceutics International Inc, Ratios based on current share price 17
Intellipharmaceutics International Inc, Annual Ratios 18
Intellipharmaceutics International Inc, Annual Ratios (Cont...1) 19
Intellipharmaceutics International Inc, Interim Ratios 21
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 23
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 24
Intellipharmaceutics International Inc, Recent Deals Summary 25
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47